Incidence of structural chromosomal anomalies in patients of acute myeloid leukemia in North Indians

Introduction: Acute myeloid leukemia (AML) is a tumor of hematopoietic progenitors caused by acquired oncogenic mutations that impede differentiation, leading to the accumulation of immature myeloid blasts in the marrow. The single most important prognostic factor in AML is cytogenetics, which determine the prognosis and probability of relapse after treatment. Hence the cytogenetic analysis of AML patients plays a great role in prognosis and treatment. Materials and Methods: Karyogram of diagnosed patients of AML was prepared from bone marrow and peripheral blood. This study was conducted in the Cytogenetic Laboratory of the Department of Anatomy, King George’s Medical University, UP, Lucknow. Patients were screened in the Department of Pediatrics Medicine and the samples were collected from there. Observations and Results: We observed the frequency of chromosomal aberrations in different age groups and sex. Out of 22 successful cases 12 cases (54.54%) exhibited abnormal karyogram and 10 cases (45.45%) showed normal karyogram. Among total 22 cases, structural chromosomal abnormalities were observed in 11 cases (50%). Translocation was present in 9 cases (40.90%), p-arm abnormality on chromosome 19 (add 19p) was present in 1 case (4.54%) and q-arm abnormality on chromosome 16 (del 16q) was present in 1 case (4.54%). Discussion and Conclusion: Translocation was found to be the most common structural anomaly in AML. We observed translocation t(8;21) in 9.09% cases. Other translocation was t(9;22) which was found in 9.09% cases.t(9;11) was observed in 9.09% cases in our study. t(15;17) was noted in 4.54% case which was also noted by previous authors. In AML t(8;21), t(15;17), inv(16) has good prognosis, intermediate prognosis is seen in abnormal 11q23, while del5q), abnormal 3q, complex cytogenetic had poor prognosis.

[1]  A. Hajifathali,et al.  Geographic Heterogeneity of Cytogenetic Characteristics of Acute Myeloid Leukemia in the early detection , 2009 .

[2]  C. Bloomfield,et al.  Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? , 2007, Blood.

[3]  W. Hiddemann,et al.  Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients , 2005, Annals of Hematology.

[4]  R. Mann,et al.  The t(8;21) translocation converts AML1 into a constitutive transcriptional repressor , 2005, Development.

[5]  D. Grimwade,et al.  The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. , 2001, Blood.

[6]  E. Thiel,et al.  Molecular genetics in acute and chronic leukemias , 2001, Journal of Cancer Research and Clinical Oncology.

[7]  R. Gray,et al.  A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial , 1999, British journal of haematology.

[8]  B. Johansson,et al.  A single‐center population‐based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender , 1999, European journal of haematology.

[9]  Y C Chen,et al.  Correlation of cytogenetic results with immunophenotype, genotype, clinical features, and ras mutation in acute myeloid leukemia. A study of 235 Chinese patients in Taiwan. , 1995, Cancer genetics and cytogenetics.

[10]  R. Gale,et al.  Adult acute leukemia. , 1994, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[11]  M. Caligiuri,et al.  Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. , 1994, Cancer research.

[12]  S. Cheong,et al.  Abnormalities of chromosome 11Q in three cases of acute myeloid leukemia. , 1992, Singapore medical journal.

[13]  A. Enjeti,et al.  Cytogenetic abnormalities in de novo acute myeloid leukemia in adults: relation to morphology, age, sex and ethnicity - a single center study from Singapore. , 2004, The hematology journal : the official journal of the European Haematology Association.

[14]  H. Kantarjian,et al.  Acute myeloid leukemia , 2018, Methods in Molecular Biology.

[15]  M. Slovak,et al.  Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. , 2000, Blood.

[16]  K. Byth,et al.  Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases , 2000, Leukemia.